In-Vitro Toxicology Testing Market Size Projected To Reach $19.18 Billion By 2034 With A Cagr Of 10.7%

The In-Vitro Toxicology Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the In-Vitro Toxicology Testing Market?
The market size of in-vitro toxicology testing has seen considerable growth in recent years, escalating from $11.53 billion in 2024 to an estimated $12.77 billion in 2025. This rapid growth, reflecting a compound annual growth rate (CAGR) of 10.7%, is driven by factors like regulatory obligations, ethical considerations related to animal wellbeing, cost and time efficiencies. It is also fueled by the globalization of the pharmaceutical sector, increased demand for drug discovery and development, and an expanding public awareness about environmental toxins.

The market size for in-vitro toxicology testing is projected to experience a substantial increase in the coming years. By 2029, the market value will reach $19.18 billion, with the Compound Annual Growth Rate (CAGR) projected at 10.7%. This growth during the forecast period is mainly due to a variety of factors such as the emphasis on personalized medicine, the need for predictive toxicology models, the broadening of environmental testing, challenges in oncology drug development, the concentration on endocrine disruptor screening, and the transition towards multi-organ chips. Other notable trends expected during this period include developments in 3D cell culture technologies, the incorporation of high-throughput screening, the focus on organ-on-a-chip technologies, their application in chemical safety evaluation, employment of human-derived cell lines, the inclusion of omics technologies, and the undertaking of educational initiatives and training programs.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7987

What Are the Different In-Vitro Toxicology Testing Market Segments?
The in-vitro toxicology testing market covered in this report is segmented -

1) By Product And Service: Consumables, Assays, Equipment, Software, Services
2) By Method: Cellular Assays, Biochemical Assays, In Silico Models, Ex Vivo Models
3) By Technology: Cell Culture Technologies, High-throughput Technologies, Toxicogenomics
4) By Applications: Neurotoxicity, Dermal toxicity, Cytotoxicity, Other Applications
5) By Industry: Pharmaceuticals And Biopharmaceuticals, Cosmetic And Household Products, Food, Chemicals

Subsegments:
1) By Consumables: Reagents, Cell Culture Media, Plates And Vials
2) By Assays: Cell-Based Assays, Biochemical Assays, Genetic Toxicity Assays
3) By Equipment: Automated Systems, Microscopes, Plate Readers
4) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Toxicology Modeling Software
5) By Services: Testing Services, Consultation Services, Regulatory Compliance Services

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7987&type=smp

What Are the Primary Drivers Shaping the In-Vitro Toxicology Testing Market?
The in-vitro toxicology testing market is anticipated to surge due to the escalating healthcare expenditure. This refers to the funds allocated by the people and the government from their total income for health services such as hospitals, home health care, prescription drugs, nursing homes, and personal health care. A global increase in health expenditure is noticeable, primarly due to the growing occurrence of diseases that require in-vitro toxicology testing. In September 2024, a report constructed by a US-based federal agency, the Centers for Medicare & Medicaid Services, projected that from 2023 to 2032, the national health expenditure (NHE) average growth rate would be 5.6%, exceeding the GDP growth rate of 4.3% by an average. Consequently, the fraction of health spending in relation to the GDP is predicted to ascend from 17.3% in 2022 to 19.7% in 2032. Therefore, this ascent in healthcare expenditure is the key driver of the in-vitro toxicology testing market.

Which Companies Are Leading in the In-Vitro Toxicology Testing Market?
Major companies operating in the in-vitro toxicology testing market are Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings (LabCorp), Gentronix Limited (a subsidiary of Eurofins Scientific SE), Bio-Rad Laboratories Inc., Eurofins Scientific SE, Charles River Laboratories International Inc., Promega Corporation, Agilent Technologies Inc., Evotec SE, SGS SA, BioIVT LLC, MB Research Laboratories LLC, Creative Biolabs Inc., Creative Bioarray Inc., InSphero AG, PerkinElmer Inc., Cyprotex PLC, MatTek Corporation, Danaher Corporation, Ncardia AG, Sekisui Chemical Co. Ltd., BioReliance Corporation, CellSystems Biotechnologie Vertrieb GmbH, Taconic Biosciences Inc., Biopredic International, MultiCell Technologies Inc., Altasciences Clinical Research Holdings Inc., Molecular Toxicology Inc., Toxys BV, XenoTech LLC, Optivia Biotechnology Inc., Toxikon Corporation

What Are the Major Trends Shaping the In-Vitro Toxicology Testing Market?
The expansion in innovative cell therapy is an emerging trend in the in-vitro toxicology market that's gaining traction. A number of prominent firms in the in-vitro toxicology testing market are concentrating on developing fresh funding solutions to establish their standing. For example, Waypoint Bio, a biotechnology firm based in the US, revealed a seed funding of $14.5 million in June 2024 for the development of new cell therapies for solid tumors using in vivo spatial pooled screening technology. This unique platform merges spatial biology with pooled screening, enabling the concurrent examination of the interactions between various cell therapy candidates and the solid tumor environment. It can evaluate hundreds of phenotypes at the single-cell level, facilitating insight into not only which therapies are successful but also the reasons behind their success or failure, based on their interactions within the tumor setting.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

What Are the Top Revenue-Generating Geographies in the In-Vitro Toxicology Testing Market?
North America was the largest region in the in- vitro toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the in- vitro toxicology testing market report during the forecast period. The regions covered in the in-vitro toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the In-Vitro Toxicology Testing Market?
2. What is the CAGR expected in the In-Vitro Toxicology Testing Market?
3. What Are the Key Innovations Transforming the In-Vitro Toxicology Testing Industry?
4. Which Region Is Leading the In-Vitro Toxicology Testing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.